华北制药：关于公司获得《药品注册证书》的公告

Group 1 - The core point of the article is that North China Pharmaceutical has received the drug registration certificate for Adenosylcobalamin capsules (0.5mg) from the National Medical Products Administration [2] Group 2 - The approval of the drug registration certificate indicates a significant regulatory milestone for the company [2] - This development may enhance the company's product portfolio and market competitiveness in the pharmaceutical industry [2] - The introduction of Adenosylcobalamin capsules could potentially meet the growing demand for vitamin B12 supplements in the market [2]